Psilos Group, a digital health venture investment firm notes, in its 2016 Outlook Report which outlines emerging healthcare trends, that digital therapeutics will amount to a $6 billion market opportunity by 2021. The Psilos report further elaborates that digital therapeutics improves health outcomes by addressing chronic conditions through behavioral changes, before they become worse. And that the new generation of digital therapeutics is demonstrating clinical efficacy by marrying the latest developments in behavioral economics, smartphones, game-ification, biometric sensors, data analytics and artificial intelligence. The long-term goal of digital therapeutics is to bend the healthcare cost curve. Download a PDF of the full Psilos report here.